Anthera Pharmaceuticals

Anthera Pharmaceuticals, Inc. (nasdaq: ANTH) is a pharmaceutical company that specializes in developing treatments for serious cardiovascular and autoimmune diseases. It is headquartered in Hayward, California.

Product Candidates
Anthera has one drug in Phase III of clinical development, and two in Phase II.


 * Varespladib methyl, an investigational anti-inflammatory agent for the treatment of acute coronary syndrome.
 * Blisibimod, an investigational anti-BAFF molecule for the treatment of systemic lupus erythematosus.
 * Varespladib sodium, an investigational anti-inflammatory agent for the treatment of acute chest syndrome.